DAL vs MTNB · P/E 12, rev $61.64B vs rev $1.1M
Delta Air Lines Inc (DAL) versus Matinas BioPharma Holdings Inc (MTNB) — a side-by-side from cached financials, not a winner call.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Matinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Latest reported MTNB revenue for 2023-12-31 was $1.1M. Net income was -$22.9M. Revenue was down 65.6% from 2022-12-31 to 2023-12-31. MTNB currently screens at market cap $5.6M.
DAL currently screens at market cap $52.18B and trailing P/E 11.6. MTNB currently screens at market cap $5.6M.
Not investment advice. Open the DAL and MTNB stock pages for the full models.
Not investment advice.